Literature DB >> 10466807

Cellular transcription factors regulate human papillomavirus type 16 gene expression by binding to a subset of the DNA sequences recognized by the viral E2 protein.

Hannah Lewis1, Kenneth Webster1, Ana-Maria Sanchez-Perez1, Kevin Gaston1.   

Abstract

Human papillomavirus type 16 (HPV-16) is a DNA tumour virus that has been implicated in the development of cervical cancer. The HPV-16 E2 protein binds to four sites that are present upstream of the viral P97 promoter and regulates transcription of the E6 and E7 oncogenes. Here, it is shown that cellular transcription factors bind to two of these E2 sites. One cellular E2 site-binding factor, which is here named CEF-1, binds tightly to E2 site 1. CEF-2, an unrelated cellular E2 site-binding factor, binds tightly to E2 site 3. Transient transfection studies performed in the absence of the E2 protein showed that mutations that blocked the binding of CEF-1 to E2 site 1 or CEF-2 to E2 site 3 significantly reduced P97 promoter activity. Further characterization of CEF-1 indicated that this factor has not previously been identified and that CEF-1 and E2 competed for binding at E2 site 1.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10466807     DOI: 10.1099/0022-1317-80-8-2087

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  6 in total

1.  A higher degree of methylation of the HPV 16 E6 gene is associated with a lower likelihood of being diagnosed with cervical intraepithelial neoplasia.

Authors:  Chandrika J Piyathilake; Maurizio Macaluso; Ronald D Alvarez; Min Chen; Suguna Badiga; Jeffrey C Edberg; Edward E Partridge; Gary L Johanning
Journal:  Cancer       Date:  2010-10-13       Impact factor: 6.860

2.  Study of viral integration of HPV-16 in young patients with LSIL.

Authors:  G Gallo; M Bibbo; L Bagella; A Zamparelli; F Sanseverino; M R Giovagnoli; A Vecchione; A Giordano
Journal:  J Clin Pathol       Date:  2003-07       Impact factor: 3.411

3.  Orientation of a novel DNA binding site affects human papillomavirus-mediated transcription and replication.

Authors:  C D Newhouse; S J Silverstein
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

4.  Modification of papillomavirus E2 proteins by the small ubiquitin-like modifier family members (SUMOs).

Authors:  Yu-Chieh Wu; Ashley A Roark; Xue-Lin Bian; Van G Wilson
Journal:  Virology       Date:  2008-07-11       Impact factor: 3.616

5.  Effects of Methylation Status of CpG Sites within the HPV16 Long Control Region on HPV16-Positive Head and Neck Cancer Cells.

Authors:  Chunlin Zhang; Zeyi Deng; Xiaoli Pan; Takayuki Uehara; Mikio Suzuki; Minqiang Xie
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

6.  Sequence variation in the E2-binding domain of HPV16 and biological function evaluation in Tunisian cervical cancers.

Authors:  Saloua Kahla; Lotfi Kochbati; Samia Hammami; Mohamed Badis Chanoufi; Mongi Maalej; Ridha Oueslati
Journal:  Biomed Res Int       Date:  2014-06-17       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.